Conferences and symposiums REPRESSIT or not: What is the future of immune checkpoint inhibitors?
16-06-2026 9:00 am - 5:00 pm Add to iCal
Campus Solna Jacob Berzelius lecture hall, Berzelius väg 3
This symposium brings together scientists with different and unique expertise, including immunology, protein design, and therapeutic development, to share their knowledge and experiences.
The symposium will include speakers in cancer biology, immunology, protein design, and biological imaging to share their work and provide a platform for open discussion.
Program
09:00-09:10
Introductory remarks and project introduction
09:10-10:35
Microscopy and imaging innovation
10:35-11:05
Coffee
11:05-12:30
Immune synapse and signaling
12:30-13:30
Lunch
13:30-14:55
RIPR, engager and checkpoint design
14:55-15:25
Coffee
15:25-16:50
T and NK cell engineering / Clinical translation of ICI, CAR-T and other immunotherapies
16:50-17:00
Conclusion
About REPRESSIT
REPRESSIT is an EU program focused on the development of proteins to regulate immune checkpoint receptors through the induced proximity of CD45 and immune inhibitory receptors. The project contains research groups spanning protein engineering, advanced fluorescence microscopy, and characterization of immune cell function and signaling.